About
Three decades on the CRO side. Now entirely on yours.
BioEquiv was founded to give pharmaceutical sponsors the kind of insider knowledge that is normally only available to the people quoting them.
We advise sponsors on bioequivalence and bioanalysis study design, CRO and site selection, and what a study should actually cost. Our perspective comes from the other side of the table: more than 30 years in pharmaceutical R&D, and over 3,000 bioequivalence, bioavailability, and pharmacokinetic studies quoted, designed, and managed for submission to the EMA, US FDA, and WHO.
That history is why we can tell you whether a quote is fair, which CRO is genuinely equipped for your protocol, and where a study design is likely to meet resistance from reviewers. We work only for sponsors — never for the CROs and sites we assess.
We are co-organizers of the MENA Regulatory Conference on Bioequivalence, Biowaivers, Bioanalysis, and Dissolution, held in four editions in partnership with AAPS, EUFEPS, FIP, and TUFTAD. Consultations are available in Arabic, English, and Spanish.
Our vision
Strengthening Jordan as a hub for clinical research
Jordan’s bioequivalence and bioanalysis CROs and clinical trial sites hold genuine expertise and infrastructure. By highlighting those standards, we aim to attract international sponsors and foster collaborations that raise the country’s standing in global clinical research.
We advocate for ethical and reliable clinical research practice. Sponsors place enormous weight on selecting the right CRO or clinical site, and we offer impartial guidance through a decision that is harder to reverse than it first appears.
In practice that means protecting sponsors from missteps that could jeopardize their credibility or regulatory standing — matching each sponsor to what their study actually needs, and giving them the information to make that decision themselves.
Work with us
Independent advice on study design, CRO selection, and what your study should actually cost.